Wire report
Big pharma accused of ‘free-riding on nature’ as global fund attracts just $7,000
The Cali Fund, set up to raise $1bn a year for biodiversity from drug companies, remains near empty Big pharmaceutical companies have been accused of “free-riding on nature”, after a landmark biodiversity fund that invites businesses to put some of their profits back into conservation was left virtually empty. The Cali Fund set out to raise $1bn (£750m) annually, by asking companies that profit from nature’s genetics to contribute towards conservation in low-income countries. But more than 18 months after the fund was launched, it remains far below this target. Continue reading...
coverage / Wire report
Get updates, read source context, send useful records, share the story, or support the reporting work from the reading page.
The Cali Fund, set up to raise $1bn a year for biodiversity from drug companies, remains near empty Big pharmaceutical companies have been accused of “free-riding on nature”, after a landmark biodiversity fund that invites businesses to put some of their profits back into conservation was left virtually empty. The Cali Fund set out to raise $1bn (£750m) annually, by asking companies that profit from nature’s genetics to contribute towards conservation in low-income countries. But more than 18 months after the fund was launched, it remains far below this target. Continue reading...
Check the original link, updates, and responses when a detail is contested.
Open topic or search related wording such as records, sources, agencies, dates, and locations.
What happened
According to The Guardian’s source item, Big pharma accused of ‘free-riding on nature’ as global fund attracts just $7,000, The Cali Fund, set up to raise $1bn a year for biodiversity from drug companies, remains near empty Big pharmaceutical companies have been accused of “free-riding on nature”, after a landmark biodiversity fund that invites businesses to put some of their profits back into conservation was left virtually empty. The Cali Fund set out to raise $1bn (£750m) annually, by asking companies that profit from nature’s genetics to contribute towards conservation in low-income countries. But more than 18 months after the fund was launched, it remains far below this target. Continue reading…
Context
The development sits in VINI’s Science file for readers following research, health, climate, space, medicine, and scientific institutions. The original report is linked so readers can check the source account, follow later updates, and compare new coverage against the first published record. The source item is dated 2026-10-22T09:00:59+00:00.
What to watch
Open questions include whether primary sources issue follow-up statements, whether local or market impacts become clearer, and whether additional reporting changes the timeline or adds material context.
Source
Primary source: Big pharma accused of ‘free-riding on nature’ as global fund attracts just $7,000 via The Guardian. VINI cites and links the source; it does not reproduce the publisher’s full article text without rights clearance.
Keep following
This file can keep developing
vininews.com uses reader tips, public records, right-of-reply requests, corrections, and follow-up reporting to keep important stories current.
Support and subscriptions never buy coverage, placement, suppression, or corrections.
This VINI report keeps the original publisher link available and does not republish third-party article bodies without rights clearance. 1 reference listed.
Source links
- Big pharma accused of ‘free-riding on nature’ as global fund attracts just $7,000The Guardian - 2026-10-22T09:00:59+00:00
Reader comments
Moderated discussion
Comments are open to authenticated approved accounts, screened for spam and abuse, and published only after newsroom moderation unless editors change the story control.
No approved comments yet.
Substantive, civil comments can be submitted by approved account holders.